secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0000950170-24-071082
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences shareholders approve increase of 630,000 shares in incentive plan
--------------------------------------------------------------------------------

- Shareholders elected Stanley R. Frankel, M.D. and Samuel Wadsworth, Ph.D. as Class II directors for term until 2027.
- Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 5,162,463 votes for.
- Amendment to 2019 Incentive Award Plan approved, increasing share reserve by 630,000 shares; 2,597,767 for, 836,298 against.
- Adjournment proposal approved with 2,649,161 votes for, if needed to solicit additional proxies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000095017024071082/0000950170-24-071082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000095017024071082/dtil-20240604.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-071082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer